Andrew Dudum serves as Executive at Hims & Hers Health, Inc., where they oversee executive responsibilities. Since joining the company, Andrew Dudum has executed 201 insider transactions totaling $132.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 20, 2021 involved receiving (via award) 8,268,565 shares valued at $0.
Andrew Dudum currently holds 969,392 shares of Hims & Hers Health, Inc. (HIMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Dudum has been a net seller of HIMS stock. They have purchased $7.8K and sold $132.2M worth of shares.
Andrew Dudum's most recent insider trade was on Jan 20, 2021, when they sold 8,268,565 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted